<DOC>
	<DOCNO>NCT00312351</DOCNO>
	<brief_summary>The purpose trial compare ability three different dos pegaptanib sodium safely effectively minimize fluid leakage within eye , thereby stabilize improve vision patient wet AMD . The study also examine effect pegaptanib sodium cornea sensory retina patient wet AMD .</brief_summary>
	<brief_title>A Clinical Trial Explore Safety Efficacy Three Different Doses Pegaptanib Sodium Patients With Wet Age-Related Macular Degeneration ( AMD )</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Subjects either gender , age 50 year great . Subfoveal choroidal neovascularization ( CNV ) due AMD . Best correct visual acuity study eye 20/40 20/320 . Normal electroretinogram , corneal endothelial cell density 1500 cells/mm2 . Any prior photodynamic therapy ( PDT ) Visudyne thermal laser study eye .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>AMD</keyword>
	<keyword>Age-Related Macular Degeneration</keyword>
	<keyword>Macular Degeneration</keyword>
	<keyword>Macugen</keyword>
	<keyword>pegaptanib sodium</keyword>
	<keyword>ERG</keyword>
	<keyword>specular microscopy</keyword>
	<keyword>Age-Related Mcular Degeneration ( AMD )</keyword>
</DOC>